Company Filing History:
Years Active: 2021
Title: Innovations of Xiaolin Zhang in Medical Applications
Introduction
Xiaolin Zhang is a prominent inventor based in Shenyang, China. He has made significant contributions to the field of medicine, particularly in the area of cardiac health. His innovative work focuses on the medical applications of the CREG protein, which has the potential to transform treatment options for various heart conditions.
Latest Patents
Xiaolin Zhang holds 1 patent related to the medical use of Cellular Repressor of E1A-stimulated Genes (CREG). This patent outlines the use of CREG protein or its active fragments in the manufacture of medicaments aimed at preventing and treating myocardial infarction. Additionally, it addresses the prevention and treatment of ventricular remodeling after myocardial infarction and heart failure, as well as myocardial ischemia-reperfusion injury and salt-sensitive hypertensive myocardial fibrosis.
Career Highlights
Xiaolin Zhang is affiliated with the General Hospital of Chinese PLA Northern Theater Command. His work at this institution has allowed him to collaborate with other experts in the field, enhancing the impact of his research and innovations.
Collaborations
Some of his notable coworkers include Yaling Han and Chenghui Yan. Their collaborative efforts contribute to the advancement of medical research and the development of effective treatments.
Conclusion
Xiaolin Zhang's innovative work in the medical field, particularly regarding the CREG protein, showcases his commitment to improving cardiac health. His contributions have the potential to lead to significant advancements in the treatment of heart-related conditions.